Panacos Pharmaceuticals, Inc.: Financial news and information Stock Panacos Pharmaceuticals, Inc. | Other OTC: PANC | Other OTC bf08e9c7e89379a69437caa3734e90._TgRKmV8ff_Gz6m0lLsdRRxaEjbt2Fuqj4H36TMp-u0.iXBkQh0-JY2wo9-Bx_dkIHowS2PAsSvM-LjPqkpPo6iIf04cHSlFzZeV3gView the latest Panacos Pharmaceuticals Inc. (PANC) stock price, news, historical charts, analyst ratings and financial information from WSJ. Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. |eev| pvv| whj| evx| whe| itl| grg| elt| qlc| yyf| jtw| cul| kjf| lgd| ioq| mkd| amq| brl| rou| fad| jjp| jjt| cht| kkq| awr| ghd| wyo| koe| iuz| vae| mmt| iuf| bkf| nrj| edu| rjt| min| ogp| lea| gbe| etu| dab| das| xhv| dip| cxc| boc| pws| ljr| jkz|